What autoimmune disease causes scleritis
What autoimmune disease causes scleritis Scleritis is a serious inflammatory condition affecting the sclera, the white outer layer of the eye. It often manifests with severe eye pain, redness, and sometimes visual disturbances. While it can occur due to isolated ocular issues, a substantial number of cases are linked to systemic autoimmune diseases. Understanding the connection between autoimmune disorders and scleritis is crucial for accurate diagnosis and effective management.
Autoimmune diseases are conditions in which the immune system mistakenly attacks the body’s own tissues, leading to inflammation and tissue damage. Several autoimmune disorders have been associated with scleritis, but the most common culprit is rheumatoid arthritis (RA). RA is a chronic inflammatory disease primarily affecting the joints, but it can also involve various organs, including the eyes. Approximately 25-30% of individuals with rheumatoid arthritis may develop scleritis at some point, often indicating active or severe disease. The inflammation in RA-driven scleritis results from immune complexes depositing in the scleral tissue, triggering an inflammatory response.
Another autoimmune condition frequently linked to scleritis is granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis. GPA is characterized by inflammation of small- to medium-sized blood vessels and can affect the respiratory tract, kidneys, and eyes. Scleritis in GPA often presents as a necrotizing form, which can be particularly aggressive and destructive. The presence of anti-neutrophil cytoplasmic antibodies (ANCA) is a hallmark of GPA, and their detection can aid in diagnosis. The immune response in GPA leads to vasculitis, causing ischemia and inflammation of the scleral tissue.
Polymyositis and dermatomyositis are other autoimmune diseases associated with scleritis, although less commonly. These conditions primarily affect muscles and skin but can also involve ocular tissues. The autoimmune mechanism involves immune-mediated muscle and skin inflammation that can extend to nearby ocular structures, resulting in scleritis or episcleritis.
Systemic lupus erythematosus (SLE) is another autoimmune disorder that can cause various ocular manifestations, including scleritis. SLE involves widespread immune complex deposition across multiple tissues, leading to inflammation. While more commonly associated with other eye problems like dry eye or retinopathy, scleritis can occur in SLE patients, often reflecting systemic disease activity.
Managing scleritis related to autoimmune diseases requires a multidisciplinary approach. Treatment aims to control both the ocular inflammation and the underlying systemic condition. This typically involves corticosteroids to reduce inflammation, along with immunosuppressive agents such as methotrexate, azathioprine, or cyclophosphamide, depending on the severity and the specific autoimmune disease involved. Early diagnosis and appropriate therapy are vital to prevent complications like scleral thinning, perforation, or vision loss.
In conclusion, autoimmune diseases play a significant role in the development of scleritis, with rheumatoid arthritis, granulomatosis with polyangiitis, and systemic lupus erythematosus being among the most common culprits. Recognizing the systemic connection can lead to prompt treatment, preserving vision and improving overall health outcomes.
